The effectiveness of the combination of axillary reverse mapping and lymphaticovenous bypass in reducing lymphedema risk in breast cancer patients has made it the standard of care for women undergoing axillary lymphadenectomy at Cleveland Clinic.
Indocyanine green (ICG) with near infrared (NIR) imaging is the standard for lymphatic mapping in Japan and Europe. A first-in-U.S. study compares it to 99mTc in breast cancer patients.
Can exercise intervention reduce racial and socioeconomic disparities in outcomes of breast cancer survivors over age 65? IMPROVE study is ongoing.
Adding the PI3K inhibitor alpelisib to antiestrogen therapy could be a major breakthrough in treating estrogen-receptor-positive metastatic or advanced breast cancers.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
What’s the ideal radiation therapy approach after breast-conserving surgery for early-stage breast cancer? A new study compares cost-effectiveness of accelerated partial breast and hypofractionated whole breast irradiation.
With his new, five-year, $1.8 million award, Dr. Gong hopes to improve PARPi therapy by better understanding the mechanisms of resistance.
Multigene panel testing should be considered for all African-American women with triple-negative breast cancer regardless of their age or cancer history.
A new option proves effective for patients with HER2+ early breast cancer with residual disease after neoadjuvant therapy.
In patients receiving radiation after mastectomy, 10-year outcomes show autologous breast reconstruction has fewer complications and reconstruction failures.
Immunotherapy hasn’t benefited breast cancer patients — yet. Breast medical oncologist Megan Kruse, MD, explains how that may be changing.